Impact of Repeated Anthelmintic Treatment on the Risk of Malaria in Kenyan School Children

Trial Profile

Impact of Repeated Anthelmintic Treatment on the Risk of Malaria in Kenyan School Children

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Oct 2015

At a glance

  • Drugs Albendazole (Primary)
  • Indications Ascariasis; Helminthiasis; Hookworm infections; Malaria
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Oct 2015 New source identified and integrated (ClinicalTrials.gov NCT01658774).
    • 15 Oct 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top